Ifp Advisors, Inc Prelude Therapeutics Inc Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 34 shares of PRLD stock, worth $42. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$42% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding PRLD
# of Institutions
48Shares Held
27.8MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$13.6 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$12.7 Million0.08% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$1.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA993KShares$1.24 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD928KShares$1.16 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $45.5M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...